Summit Therapeutics (SMMT) - 2025 Q3 - Earnings Call Presentation

Summit Therapeutics ESMO Update & Q3 2025 Earnings Call October 20, 2025 8:00am ET Forward Looking Statement Any statements in this press release about the Company's future expectations, plans and prospects, including but not limited to, statements about the clinical and preclinical development of the Company's product candidates, entry into and actions related to the Company's partnership with Akeso Inc., the Company's anticipated spending and cash runway, the therapeutic potential of the Company's product ...